According to the latest report by IMARC Group, the global infertility drugs market reached a value of US$ 3.47 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 4.95 Billion by 2027 exhibiting a CAGR of 5.70% during 2022-2027.
Infertility drugs consist of numerous medications that are used to treat infertility and improve the reproductive health of an individual. Some of the commonly used infertility drugs include aromatase inhibitors, gonadotrophins, biguanides, ovulatory stimulants, selective estrogen receptor modulators (SERMs), dopamine agonists, tricyclic antidepressants, etc. These drugs function by stimulating ovulation and follicle development of the ovary in women, as well as help to restore testosterone levels and improve the quality of sperm in men.
|Base Year: 2021|
|Forecast Year: 2022-2027|
Infertility Drugs Market Trends and Drivers:
The growing incidences of infertility and miscarriages, particularly among the modern couples, are primarily driving the adoption of infertility drugs. In line with this, the rising consumer awareness towards several benefits of infertility drugs in enhancing the chances of pregnancy in couples is also augmenting the market growth on a global level.
Request Free Sample Report: https://www.imarcgroup.com/infertility-drugs-market/requestsample
Furthermore, numerous initiatives are being undertaken by the NGOs and leading product manufacturers for improving the visibility of the available treatment options, thereby catalyzing the demand for infertility drugs. Additionally, various key players are investing in R&D activities to launch innovative infertility drugs with enhanced efficacy, fewer side effects, lower dosage requirements, etc.
Several other factors, including the escalating demand for generic medicines, rising consumer expenditure capacities, improving healthcare infrastructure, etc., are expected to drive the global infertility drugs market in the coming years.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Infertility Drugs Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.
The report has segmented the market on the basis of region, drug class, route of administration, distribution channel and end user.
Breakup by Drug Class:
- Aromatase Inhibitors
- Selective Estrogen Receptor Modulators (SERMs)
Breakup by Route of Administration:
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
Breakup by End User:
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/infertility-drugs-market
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800